Overview Study to Evaluate the Safety and Pharmacokinetics of CKD-349 Status: Not yet recruiting Trial end date: 2021-12-06 Target enrollment: Participant gender: Summary Study to Evaluate the Safety and Pharmacokinetics of CKD-349 Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical